Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karalyne Crowder"'
Autor:
Matthew Levengood, Chris Leiske, Noah Bindman, Xinqun Zhang, Nicole Duncan, Weiping Zeng, Serena Wo, Abbie Wong, Clark Henderson, Karalyne Crowder, Haley Neff-LaFord, Django Sussman, Shyra Gardai, Philip Moquist
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca16c591e415cb65eb959c058004bae0
https://doi.org/10.1136/jitc-2022-sitc2022.1357
https://doi.org/10.1136/jitc-2022-sitc2022.1357
Autor:
Ponraj Prabakaran, Lili Wang, Yang Feng, Rui Gong, Tianlei Ying, Yanping Wang, Dimiter S. Dimitrov, Karalyne Crowder
Publikováno v:
mAbs. 7:922-930
Engineered antibody domains (eAds) are promising candidate therapeutics but their half-life is relatively short partly due to weak or absent binding to the neonatal Fc receptor (FcRn). We developed a novel approach to increase the eAd binding to FcRn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a67fb142195398a4a86a55e702034b
https://doi.org/10.1080/19420862.2015.1067353
https://doi.org/10.1080/19420862.2015.1067353
Publikováno v:
Experimental and molecular pathology. 97(3)
The insulin-like growth factor 2 (IGF2) is an important target for cancer therapy. We have previously proposed an approach for fast and irreversible removal of IGF2 from the circulation by using monoclonal antibodies (mAbs) that bind to two or more n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39d76d38cbd8e8ac96f3cdea75881aa
https://pubmed.ncbi.nlm.nih.gov/25220345
https://pubmed.ncbi.nlm.nih.gov/25220345